Catalyst Wire Dossier Catalyst Wire Dossier

CD5 CAR-T

CD5-targeted CAR-T cell therapy · Institute of Hematology & Blood Diseases Hospital, China
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD5 CAR-T, covering 2025-11-18 to 2025-11-18. Get the full timeline:

Most recent: Clinical Trial Update: CD5 CART for the Treatment of Relapsed and Refractory CD5 Hematological Tumors [NA]

See pricing